Location History:
- Manhattan, KS (US) (2007)
- Tea, SD (US) (2010)
Company Filing History:
Years Active: 2007-2010
Title: Eddie Sullivan: Innovator in Transgenic Technology
Introduction
Eddie Sullivan is a notable inventor based in Tea, South Dakota, who has made significant contributions to the field of biotechnology. With a focus on transgenic ungulates and cloning methods, he holds 2 patents that showcase his innovative approach to producing human antibodies and cloning mammals.
Latest Patents
One of Sullivan's latest patents is titled "Transgenic ungulates capable of human antibody production." This invention features novel methods for producing large quantities of xenogenous antibodies, particularly human antibodies. The process involves inactivating IgM heavy chain expression and optionally Ig light chain expression, along with the introduction of an artificial chromosome that facilitates the expression of these antibodies.
Another significant patent is "Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells." This invention provides methods for cloning mammals that enable the reprogramming of donor chromosomes or cells before their insertion into an enucleated oocyte. It also includes methods for inserting chromosomes or nuclei into recipient cells.
Career Highlights
Throughout his career, Eddie Sullivan has worked with various companies, including Aurox, LLC and Kyowa Hakko Kirin Co., Limited. His work has been instrumental in advancing the understanding and application of transgenic technologies.
Collaborations
Sullivan has collaborated with notable individuals in his field, including Philippe Collas and James M Robl. These partnerships have contributed to the development of his innovative patents and research.
Conclusion
Eddie Sullivan's work in transgenic technology and cloning methods has positioned him as a key figure in biotechnology. His patents reflect a commitment to advancing scientific knowledge and practical applications in the field.